Revolutionizing the Pharmaceutical Industry

We provide innovative and cost-effective protein purification
solutions to biotech firms and researchers globally.

All about BMB in
two minutes

Learn about our company, patent-pending
technology, and where we're headed.

Boston Mountain Biotech

At Boston Mountain Biotech, we develop and patent technology that aids in the development of a new protein expression and purification platform. Currently this technology is being marketed through the Lotus® E. coli Cell Lines which demonstrate reduced host cell protein (HCP). These new reduced HCP bacterial cell lines simplify the development and manufacturing of recombinant protein therapeutics, vaccines and enzymes. At BMB, we are revolutionizing the pharmaceutical industry by providing protein purification solutions that result in new drugs moving from development to patient faster while simultaneously lowering the cost of manufacturing.



University of Arkansas graduates McKinzie Fruchtl (left) Ellen Brune form the core of the start-up company Boston Mountain Biotech. Photo by Matt Reynolds, University of Arkansas

BMB Featured on the University of Arkansas Newswire and the Northwest Arkansas Business Journal

January 21, 2015

The awarding of the Lotus patent was highlighted today both two local news groups. Check out the full articles below! […]

Read More

First Patent Awarded!

January 6, 2015

BMB’s first patent, titled “Separatome-based protein expression and purification platform” (US8927231) was issued today. This patent protects our Lotus® E. coli manufacturing platform […]

Read More